Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Beta2-adrenergic receptor gene polymorphisms and haplotypes associate with chronic pain in sickle cell disease
source: The Journal of Pain
authors: E. Jhun, Y. He, Y. Yao, D. Wilkie, R. Molokie, J. Wangsummary/abstract:
Pain in sickle cell disease (SCD) is a heterogeneous and severe phenotype that requires thorough characterization for precision therapy. The beta 2 adrenergic receptor (ADRB2) is an intronless gene in the monoamine neurotransmitter system that plays an important role in pain perception and modulation; however, its contribution to SCD pain has not been previously examined. In this study, we investigated 16 ADRB2 candidate SNPs that are located in 5’-intergenic/UTR and coding regions on chronic non-crisis pain variability in SCD. Subjects provided informed consent and recorded their pain experience on the tablet-based PAINReportIt system, from which we obtained comprehensive pain phenotypes. The Composite Pain Index (CPI) was used as a measurement for chronic pain. Using the additive multiple linear regression model adjusted for covariates, a single rs17778257 T allele was found to shift CPI by -4.39 (p=0.032). The A allele of rs12654778 caused a 4.52 decrease in the CPI (p=0.019), whereas rs11168070 G allele led to a 5.99 increase in CPI (p=0.016). Rs11959427 C allele caused a 5.69 increase in CPI (p=0.023), and 5’UTR rs1042711 C allele and rs1801704 C allele caused a 10.86 (p=0.000494) and 5.26 (p=0.031) increase, respectively. The coding SNP rs1042713 A allele (Arg16) caused a 5.73 decrease in CPI (p=0.002). Collectively, these SNPs accounted for 2-15% of the variance in CPI. Moreover, we found these SNPs are in linkage disequilibrium showing 3 LD blocks in our cohort. Haplotype analyses reveal association of CPI with a 10-marker haplotype from block 1 leading to a 10.60 increase in CPI (p=0.000341). A 2-marker haplotype from block 2 was associated with a 5.94 decrease in CPI (p=0.001). Data from this study strongly implicated significant influences of ADRB2 polymorphisms and haplotypes on chronic pain in SCD.organization: University of Illinois at Chicago
Angela Rivers, MD, PhDDr. Rivers is the Director at Sickle Cel...
Hydroxyurea effectiveness in children and adolescents with sickle cell anemia: A large retrospective, population-bas...The clinical efficacy of hydroxyurea in ...
Here to Stay — Living With Sickle Cell DiseaseMy name is Noah Alexander Williams and I...
Researchers Develop Effective Treatment for Sickle Cell Anemiahttps://www.youtube.com/watch?v=7zceTJzH...
Conversation With Women in the Sickle Cell CommunitySickle Cell Project of NW Ohio at Neighb...
Chief Patient Officer SummitJuly 18-20 | Boston, Massachusetts This...
Dana Carroll, PhDDana Carroll, PhD, is a distinguished pr...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.